2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids

Details 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids

1999-05-26

2000-06-06

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

540570, A61K 315513, C07D24314

Patent

active

060719036

ABSTRACT:
Compounds are provided having the following formula: ##STR1## wherein R, R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are defined in the specification, which have matrix metalloproteinase inhibiting activity.

REFERENCES:
patent: 5455258 (1995-10-01), MacPherson et al.
patent: 5795887 (1998-08-01), Aquino et al.
Yu, A. E. et al., Drugs and Aging, 11:229-244 (1997).
Beckett, R. P. et al., Drug Discovery Today, 1:16-26 (1996).
Beeley, N. R. A. et al., Curr. Opin. Ther. Patents 4(1):7-16 (1994).
Morphy, J. R. et al. Curr. Medicinal Chem. 2:743-762 (1995).
Davidsen, S. K., Exp. Opin. Ther. Patents 5(2):1087-1100 (1995).
Porter, J. R. et al., Exp. Opin. Ther. Patents 5(12):1287-1296 (1995).
Zask, A. et al., Current Pharmaceutical Design, 2(6):624-661 (1996).
Levy, D. E. et al., Emerging Drugs, 2:205-230 (1997).
McGeehan, G. M. et al., Current Pharmaceutical Design, 2:662-667 (1996).

Affiliated with

Also associated with

Rating

2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2213735